XPRA
TABAK
Market cap2.40bUSD
Sep 16, Last price
18,500.00CZK
1D
-1.49%
1Q
0.11%
Jan 2017
41.26%
Name
Philip Morris CR as
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Philip Morris CR a.s., through its subsidiary, Philip Morris Slovakia s.r.o., manufactures and markets tobacco products under the Marlboro, L&M, Chesterfield, Petra Klasik, Sparta, and RGD brands in the Czech Republic and the Slovak Republic. It also distributes smoke-free tobacco products under the HEETS name; IQOS tobacco heating systems; IQOS VEEV electronic cigarettes; VEEV One pods, an e-vapor product; and the Fiit and lil SOLID tobacco heating systems, and related accessories, as well as cigarettes. The company was founded in 1812 and is based in Prague, the Czech Republic. Philip Morris CR a.s. operates as a subsidiary of Philip Morris Holland Holdings B.V.
Key people
Johannes Franciscus Gerardus Vroemen
Chairman of the Supervisory Board · since 2014
Andras Tovisi
Chairman of the Management Board, Chief Executive Officer · since 2011
Stanislava Jurikova
Member of the Management Board, Finance Director · since 2012
Petr Karla
Member of the Management Board, Operations Director · since 2015
Tomas Korkos
Member of the Management Board, Director of Corporate Affairs · since 2015
Igor Potocar
Member of the Management Board and Director of Sales and Distribution · since 2010
Vaclav Beranek
Member of the Supervisory Board · since 2015
Vasileios Nomikos
Member of the Supervisory Board · since 2011
Alena Zemplinerova
Member of the Supervisory Board · since 2013
IPO date
Jul 13, 1993
Employees
1,187
Domiciled in
CZ
Incorporated in
CZ
Legal address
Vítězná 1
Kutná Hora, 20 284 03
CZ
Kutná Hora, 20 284 03
CZ
Headquarters
Karlovo náměstí 10
Praha 2, 10 120 00
CZ
Praha 2, 10 120 00
CZ
Valuation
Title CZK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||